Trump Administration Foreign Aid Review: PEPFAR Status
U.S. Global Health Programs Face Ongoing Disruption Following Policy Shifts
Important changes to U.S. foreign assistance began early in the previous administration, fundamentally altering the landscape of global health programs. Starting on the first day of the second term, a series of executive actions initiated a complete review and restructuring of how the United States approaches international aid.
The initial move was an executive order mandating a 90-day review of all foreign aid programs. This was quickly followed by a “stop-work order” that effectively froze payments and halted services for projects already in progress. The impact was immediate, creating uncertainty for organizations working on critical health initiatives worldwide.
Perhaps the most dramatic change involved the restructuring of the U.S. Agency for International Development (USAID). The agency faced dissolution, accompanied by ample reductions in both staff and contractor numbers. This downsizing substantially impacted USAID’s capacity to manage and implement global health programs.
Alongside these changes, many existing foreign assistance awards were cancelled, further compounding the disruption. While a waiver was issued to allow for the continuation of life-saving humanitarian assistance, access to this waiver proved limited. Program implementers reported difficulties navigating the requirements and securing approval, hindering their ability to deliver essential services.
Numerous legal challenges were mounted against these executive actions, seeking to restore funding and protect vital programs. However, as of late 2025, legal remedies have been limited, leaving many initiatives vulnerable. The resulting disruptions have led to the suspension and, in some instances, complete termination of U.S.-funded global health programs.
Further compounding these challenges, proposed changes within the Department of Health and Human Services (HHS), including potential budget cuts and organizational restructuring, are anticipated to have additional repercussions for global health initiatives. these internal shifts within HHS could further strain resources and limit the scope of U.S. involvement in international health efforts.
These policy shifts underscore the fragility of global health funding and the importance of sustained,predictable support for programs addressing critical health needs worldwide. Ongoing monitoring of these changes and their impact remains crucial for stakeholders in the global health community.
